Bharti, Alok C <br/><br/>
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis.  [electronic resource] 

 -  Blood  Feb 2003 
 - 1053-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2002-05-1320  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Division--drug effects<br/>Curcumin--pharmacology<br/>Down-Regulation--drug effects<br/>Drug Synergism<br/>G1 Phase--drug effects<br/>Humans<br/>I-kappa B Kinase<br/>Multiple Myeloma--drug therapy<br/>NF-kappa B--antagonists & inhibitors<br/>Phosphorylation--drug effects<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Tumor Cells, Cultured